CD28 and neoplasm: Essentially, these factors include the possession of T cells with an inherent ability to specifically recognize and have high affinity for binding to tumor-associated antigens, the ability to proliferate in response to appropriate stimuli (IL-2, CD3 cross-linking, CD28, etc.), and the ability to maintain their functionality once they arrive in the tumor microenvironment [51].